Gene Therapy Latest News | Experimental Gene Therapy Studies

Investigational Gene Therapy Increased FIX Production

04 June 2021

Data Show Potential of Roctavian Gene Therapy for Hemophilia A

19 May 2021

Gene Therapy Roctavian Prevents Bleeds Over 5 Years, Data Show

28 May 2021

Hemophilia B Gene Therapy AMT-061 Safe, Effective, Trial Data Show

14 May 2021

CSL Behring Acquires AMT-061, Hem B Gene Therapy in Phase 3 Trial
06 May 2021
Criteria for Gene Therapy Trials Can Exclude Many With Severe Hemophilia
30 April 2021
FDA Lifts Hold on uniQure’s Hemophilia B Gene Therapy Program
27 April 2021
Hemophilia B Gene Therapy AMT-061 Unlikely to Have Caused Liver Tumor
01 April 2021

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL